Invesco Biotechnology & Genome ETF
PBE
PBE
82 hedge funds and large institutions have $133M invested in Invesco Biotechnology & Genome ETF in 2015 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 27 increasing their positions, 18 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
15% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 13
22% less capital invested
Capital invested by funds: $170M → $133M (-$36.9M)
Holders
82
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$4.39M | |
| 2 | +$2.16M | |
| 3 | +$1.67M | |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$1.3M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.23M |
Top Sellers
| 1 | -$4.15M | |
| 2 | -$3.27M | |
| 3 | -$2.66M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$2.42M |
| 5 |
VF
Virtu Financial
New York
|
-$653K |